{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:09:56Z","timestamp":1792048196664,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/bf02574503","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T11:43:15Z","timestamp":1174563795000},"page":"799-806","source":"Crossref","is-referenced-by-count":56,"title":["Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms"],"prefix":"10.1007","volume":"9","author":[{"given":"Matthew F.","family":"Kalady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Clary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Gottfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Rohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Edward Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore N.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02574503_CR1","first-page":"1152","volume-title":"Textbook of Surgery: The Biological Basis of Modern Surgical Practice","author":"CJ Yeo","year":"1997","unstructured":"Yeo CJ, Cameron JL. The pancreas. In: Sabiston DC, ed.Textbook of Surgery: The Biological Basis of Modern Surgical Practice. Philadelphia: WB Saunders, 1997:1152\u201386."},{"key":"BF02574503_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"R Greenlee","year":"2000","unstructured":"Greenlee R, Murray T, Bolden S, Wingo P. Cancer statistics, 2000.CA Cancer J Clin 2000;50:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"BF02574503_CR3","volume-title":"SEER Cancer Statistics Review 1973\u20131990","author":"National Cancer Institute","year":"1993","unstructured":"National Cancer Institute.SEER Cancer Statistics Review 1973\u20131990. Bethesda, MD: National Institutes of Health, 1993."},{"key":"BF02574503_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","volume":"4","author":"TA Sohn","year":"2000","unstructured":"Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas\u2014616 patients: results, outcomes, and prognostic indicators.J Gastrointest Surg 2000;4:567\u201379.","journal-title":"J Gastrointest Surg"},{"key":"BF02574503_CR5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","volume":"226","author":"CJ Yeo","year":"1997","unstructured":"Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.Ann Surg 1997;226:248\u201357; discussion, 257\u201360.","journal-title":"Ann Surg"},{"key":"BF02574503_CR6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0016-5107(99)70050-7","volume":"49","author":"KR Reddy","year":"1999","unstructured":"Reddy KR, Levi J, Livingstone A, et al. Experience with staging laparoscopy in pancreatic malignancy.Gastrointest Endosc 1999; 49:498\u2013503.","journal-title":"Gastrointest Endosc"},{"key":"BF02574503_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archsurg.1990.01410140108018","volume":"125","author":"AL Warshaw","year":"1990","unstructured":"Warshaw AL, Gu ZY, Wittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer.Arch Surg 1990;125:230\u20133.","journal-title":"Arch Surg"},{"key":"BF02574503_CR8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s002689900593","volume":"23","author":"P Berberat","year":"1999","unstructured":"Berberat P, Friess H, Kashiwagi M, Beger HG, Buchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography.World J Surg 1999;23:882\u20137.","journal-title":"World J Surg"},{"key":"BF02574503_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0039-6109(05)70122-5","volume":"81","author":"RL Heertum van","year":"2001","unstructured":"van Heertum RL, Fawwaz RA. The role of nuclear medicine in the evaluation of pancreatic disease.Surg Clin North Am 2001;81:345\u201358.","journal-title":"Surg Clin North Am"},{"key":"BF02574503_CR10","first-page":"250","volume":"40","author":"A Frohlich","year":"1999","unstructured":"Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET.J Nucl Med 1999;40:250\u20135.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR11","first-page":"1337","volume":"38","author":"T Higashi","year":"1997","unstructured":"Higashi T, Tamaki N, Honda T, et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.J Nucl Med 1997;38:1337\u201344.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR12","first-page":"1344","volume":"38","author":"SN Reske","year":"1997","unstructured":"Reske SN, Grillenberger KG, Glatting G, et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.J Nucl Med 1997;38:1344\u20138.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002610000159","volume":"26","author":"H Jadvar","year":"2001","unstructured":"Jadvar H, Fischman AJ. Evaluation of pancreatic carcinoma with FDG PET.Abdom Imaging 2001;26:254\u20139.","journal-title":"Abdom Imaging"},{"key":"BF02574503_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mge.2000.107727","volume":"52","author":"HR Mertz","year":"2000","unstructured":"Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.Gastrointest Endosc 2000;52:367\u201371.","journal-title":"Gastrointest Endosc"},{"key":"BF02574503_CR15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00000658-199905000-00016","volume":"229","author":"DM Rose","year":"1999","unstructured":"Rose DM, Delbeke D, Beauchamp RD, et al.18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.Ann Surg 1999;229:729\u201337.","journal-title":"Ann Surg"},{"key":"BF02574503_CR16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2214\/ajr.171.6.9843289","volume":"171","author":"MT Keogan","year":"1998","unstructured":"Keogan MT, Tyler D, Clark L, et al. Diagnosis of pancreatic carcinoma: role of FDG PET.AJR Am J Roentgenol 1998;171:1565\u201370.","journal-title":"AJR Am J Roentgenol"},{"key":"BF02574503_CR17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2168.1999.01016.x","volume":"86","author":"A Imdahl","year":"1999","unstructured":"Imdahl A, Nitzsche E, Krautmann F, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.Br J Surg 1999;86:194\u20139.","journal-title":"Br J Surg"},{"key":"BF02574503_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1023\/A:1008372332584","volume":"10","author":"M Zinny","year":"1999","unstructured":"Zinny M, Buell U.18FDG-positron emission tomography in pancreatic cancer.Ann Oncol 1999;10:28\u201332.","journal-title":"Ann Oncol"},{"key":"BF02574503_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiology.195.2.7724751","volume":"195","author":"T Inokuma","year":"1995","unstructured":"Inokuma T, Tamaki N, Torizuka T, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxy-glucose: comparison with CT and US.Radiology 1995;195:345\u201352.","journal-title":"Radiology"},{"key":"BF02574503_CR20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/gut.36.5.771","volume":"36","author":"H Friess","year":"1995","unstructured":"Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.Gut 1995;36:771\u20137.","journal-title":"Gut"},{"key":"BF02574503_CR21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/BF03215860","volume":"25","author":"RK Kasperk","year":"2001","unstructured":"Kasperk RK, Riesener KP, Wilms K, Schumpelick V. Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon's view.World J Surg 2001;25:1134\u20139.","journal-title":"World J Surg"},{"key":"BF02574503_CR22","first-page":"1784","volume":"40","author":"D Delbeke","year":"1999","unstructured":"Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.J Nucl Med 1999;40:1784\u201391.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR23","first-page":"1030","volume":"39","author":"CG Diederichs","year":"1998","unstructured":"Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.J Nucl Med 1998;39:1030\u20133.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR24","first-page":"1","volume":"34","author":"P Lindholm","year":"1993","unstructured":"Lindholm P, Minn H, Leskin-Kallio S. Influence of blood glucose concentration on FDG uptake in cancer: a PET study.J Nucl Med 1993;34:1\u20136.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00003072-200002000-00007","volume":"25","author":"Y Nakamoto","year":"2000","unstructured":"Nakamoto Y, Higashi T, Sakahara H, et al. Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities.Clin Nucl Med 2000;25:115\u20139.","journal-title":"Clin Nucl Med"},{"key":"BF02574503_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","volume":"25","author":"S Adams","year":"1998","unstructured":"Adams S, Baum R, Rink T, Schumm-Drager PM, Usadel KH, Hor G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.Eur J Nucl Med 1998;25:79\u201383.","journal-title":"Eur J Nucl Med"},{"key":"BF02574503_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006676-200003000-00001","volume":"20","author":"CG Diederichs","year":"2000","unstructured":"Diederichs CG, Staib L, Vogel J, et al. Values and limitations of18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.Pancreas 2000;20:109\u201316.","journal-title":"Pancreas"},{"key":"BF02574503_CR28","first-page":"1972","volume":"33","author":"R Kubato","year":"1992","unstructured":"Kubato R, Yamada Y, Torizuka T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microradiography.J Nucl Med 1992;33:1972\u201380.","journal-title":"J Nucl Med"},{"key":"BF02574503_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002590050226","volume":"25","author":"P Shreve","year":"1998","unstructured":"Shreve P. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.Eur J Nucl Med 1998;25:259\u201364.","journal-title":"Eur J Nucl Med"},{"key":"BF02574503_CR30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s002680010182","volume":"24","author":"A Sendler","year":"2000","unstructured":"Sendler A, Avril N, Helmberger H, et al. Preoperative evaluation of pancreatic masses with positron emission tomography using18F-fluorodeoxyglucose: diagnostic limitations.World J Surg 2000;24:1121\u20139.","journal-title":"World J Surg"},{"key":"BF02574503_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9610(01)00707-3","volume":"182","author":"M Schwarz","year":"2001","unstructured":"Schwarz M, Pauls S, Sokiranski R, et al. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective?Am J Surg 2001;182:243\u20139.","journal-title":"Am J Surg"},{"key":"BF02574503_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1148\/radiology.196.1.7784573","volume":"196","author":"SC Hommeyer","year":"1995","unstructured":"Hommeyer SC, Freeny PC, Crabo LG. Carcinoma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT-potential of improved accuracy in staging.Radiology 1995;196:233\u20138.","journal-title":"Radiology"},{"key":"BF02574503_CR33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1200\/JCO.2002.20.2.388","volume":"20","author":"T Ruers","year":"2002","unstructured":"Ruers T, Langenhoof B, Neeleman N, et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.J Clin Oncol 2002;20:388\u201395.","journal-title":"J Clin Oncol"},{"key":"BF02574503_CR34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s10434-001-0758-1","volume":"8","author":"R White","year":"2001","unstructured":"White R, Hurwitz H, Lee C, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.Ann Surg Oncol 2001; 8:758\u201365.","journal-title":"Ann Surg Oncol"},{"key":"BF02574503_CR35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000658-200111000-00014","volume":"234","author":"C Sperti","year":"2001","unstructured":"Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.Ann Surg 2001;234:675\u201380.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02574503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02574503\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02574503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T16:30:30Z","timestamp":1558197030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02574503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["BF02574503"],"URL":"https:\/\/doi.org\/10.1007\/bf02574503","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}